Generex Provides Clarification for Special Meeting Voting
WORCESTER, Mass., Oct. 14 /PRNewswire/ -- Generex Biotechnology Corporation (Nasdaq: GNBT) (www.generex.com) advises its stockholders that votes cast in respect of the reverse stock split proposal put forward at the Annual Meeting of the Company's stockholders held on July 28, 2010 DO NOT COUNT as votes cast in respect of the reverse stock split proposal being put forward at the Special Meeting of stockholders scheduled for 10 a.m. EDT on Friday, October 15, 2010. In order to vote in respect of the current reverse stock split proposal, stockholders must cast their votes using the proxy form issued for the Special Meeting.
Stockholders whose stock is held on their behalf by brokerage houses may not have received the proxy solicitation materials, including proxy forms, in respect of the Special Meeting. Those stockholders are urged to contact their brokers or the brokerage proxy department in order to vote their stock at the Special Meeting.
Stockholders may also fax completed proxy forms for the Special Meeting (with the control number(s) and both sides of the proxy form) to Generex at 1-416-364-9363 up until 10 a.m. EDT tomorrow.
Should stockholders have any questions regarding the proxy voting procedures (including changing previously cast votes), please contact Legend Securities, Inc. by telephone at 877-317-7526 or via email at email@example.com for US residents. Non-US residents should contact Generex directly at 800-391-6755 or contact their broker/dealer.
About Generex Biotechnology Corporation
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the de